Dendritic cell-activated cytokine-induced killer cells - Shanghai Jia Fu Medical

Drug Profile

Dendritic cell-activated cytokine-induced killer cells - Shanghai Jia Fu Medical

Alternative Names: Autologous dendritic cell cytokine-induced killer cell therapy - Shanghai Jia Fu Medical; DC CIK biotherapy - Shanghai Jia Fu Medical Apparatus; DC-activated CIK - Shanghai Jia Fu Medical Apparatus; DC-CIK - Shanghai Jia Fu Medical Apparatus; DCIK - Shanghai Jia Fu Medical Apparatus; Dendritic cell cytokine-induced killer cell therapy - Shanghai Jia Fu Medical

Latest Information Update: 18 Jul 2012

Price : $50

At a glance

  • Originator Shanghai Jia Fu Medical Apparatus
  • Class Cell therapies; Dendritic cell vaccines
  • Mechanism of Action Cytokine induced killer cell modulators; Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Cancer

Most Recent Events

  • 13 Jul 2012 Product launched for Cancer (Parenteral) before July 2012
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top